Now hopefully Oncosec has learned from previous mistakes and the registration trial gets underway without the delays of the current phase II trial which seriously hurt investor sentiment and sunk the stock price since uplifting to the Nasdaq. Good combo results in the next few months + swift enrollment in the registration trial will lead to an early approval and commercialization. Go Oncosec! Make it happen!